Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/annonc/mdn633 | DOI Listing |
Publication Analysis
Top Keywords
reply adjuvant
4
adjuvant chemotherapy
4
chemotherapy prognosis
4
prognosis patients
4
patients breast
4
breast cancer
4
reply
1
chemotherapy
1
prognosis
1
patients
1
Similar Publications
Reply to: Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Addressing Statistical and Methodological Concerns in Survival Analysis.
J Clin Oncol
January 2025
Joseph R. Habib, MD, Ammar A. Javed, MD, and Christopher L. Wolfgang, MD, PhD, New York University Grossman School of Medicine, New York, NY.
Author's reply to the Letters to the Editor. Six years duration of adjuvant imatinib in high-risk GIST: more to come.
Ann Oncol
December 2024
Institut Gustave Roussy, Villejuif, France.
Adjuvant nivolumab for gastric and gastro-oesophageal junction cancer - Authors' reply.
Lancet Gastroenterol Hepatol
December 2024
Department of Surgery, Yodogawa Christian Hospital, Osaka 533-0024, Japan. Electronic address:
Reply to Commentary on "Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma".
Cancer Res Treat
January 2025
Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!